Group | Average body-weight gain (g) | Relative body-weight gain (%) | Mean lesion scores | Decreased oocyst output (%) | ACI |
---|---|---|---|---|---|
Unchallenged control | 79.97 ± 18.85f | 100 | 0 ± 0a | 100 | 200 |
Challenged control | 54.34 ± 20.57bc | 68.40 | 2.61 ± 0.37h | 0 | 102.23 |
pVAX1 control | 52.80 ± 19.10ab | 71.04 | 1.65 ± 0.64bcd | 12.50 | 114.46 |
Pool 3–1 | 42.06 ± 23.21a | 52.88 | 2.25 ± 0.55fg | 51.39 | 120.38 |
Pool 3–2 | 48.79 ± 22.91a | 63.82 | 2.50 ± 0.76gh | 31.11 | 128.82 |
Pool 3–3 | 47.96 ± 22.10ab | 61.75 | 1.85 ± 0.36cde | 51.39 | 133.25 |
Pool 3–4 | 42.81 ± 36.90ab | 54.88 | 2.20 ± 0.57f | 40.56 | 127.88 |
Pool 7–1 | 60.47 ± 28.12cd | 79.86 | 1.50 ± 0.48b | 36.11 | 144.86 |
Pool 7–2 | 54.49 ± 30.97bc | 69.62 | 1.57 ± 0.70bc | 69.44 | 143.85 |
Pool 7–3 | 60.14 ± 16.57cd | 79.75 | 1.93 ± 0.45cde | 70.83 | 150.42 |
Pool 7–4 | 60.58 ± 21.90cd | 82.32 | 1.64 ± 0.49bcd | 52.78 | 155.85 |
Pool 8–1 | 64.21 ± 15.77de | 82.55 | 1.63 ± 0.61bcd | 50.00 | 156.22 |
Pool 8–2 | 76.23 ± 18.14ef | 94.77 | 1.75 ± 0.54bcde | 88.89 | 172.27 |
Pool 8–3 | 60.58 ± 19.20cd | 81.82 | 2.00 ± 0.44def | 31.94 | 141.82 |
Pool 8–4 | 69.19 ± 21.47def | 83.58 | 2.05 ± 0.34e | 56.94 | 152.99 |